Found: 14
Select item for more details and to access through your institution.
Pharmacokinetics of the chimeric anti-GD2 antibody, ch14.18, in children with high-risk neuroblastoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Healthcare utilization disparities among children with high‐risk neuroblastoma treated on Children's Oncology Group clinical trials.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 10, p. 1, doi. 10.1002/pbc.31192
- By:
- Publication type:
- Article
Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31089
- By:
- Publication type:
- Article
A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31086
- By:
- Publication type:
- Article
Multimodality treatment for recurrent neuroblastoma in the central nervous system.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 4, p. 1, doi. 10.1002/pbc.30227
- By:
- Publication type:
- Article
Significance of CNS 2 cerebrospinal fluid status post-induction in pediatric and adolescent patients with acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Resource utilization and toxicities after single versus tandem autologous stem cell rescue in high‐risk neuroblastoma using a national administrative database.
- Published in:
- Pediatric Blood & Cancer, 2018, v. 65, n. 12, p. N.PAG, doi. 10.1002/pbc.27372
- By:
- Publication type:
- Article
Resource Utilization and Toxicities After Carboplatin/Etoposide/Melphalan and Busulfan/Melphalan for Autologous Stem Cell Rescue in High-Risk Neuroblastoma Using a National Administrative Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Establishing a high-risk neuroblastoma cohort using the pediatric health information system database.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 6, p. 1129, doi. 10.1002/pbc.24930
- By:
- Publication type:
- Article
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 7, p. e2116248, doi. 10.1001/jamanetworkopen.2021.16248
- By:
- Publication type:
- Article
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
- Published in:
- Neuro-Oncology, 2022, v. 24, p. 1776, doi. 10.1093/neuonc/noac087
- By:
- Publication type:
- Article
Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 15, p. 2967, doi. 10.1002/cncr.34263
- By:
- Publication type:
- Article
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article